Efficacy and tolerability of an IFN-free regimen with DCV/ASV for elderly patients infected with HCV genotype 1B-Reference-Cited by-同舟云学术

Efficacy and tolerability of an IFN-free regimen with DCV/ASV for elderly patients infected with HCV genotype 1B

Published:2017-03 Issue:3 Volume:66 Page:521-527
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Toyoda Hidenori,Kumada Takashi^ORCID,Tada Toshifumi,Shimada Noritomo,Takaguchi Koichi,Senoh Tomonori,Tsuji Kunihiko,Tachi Yoshihiko,Hiraoka Atsushi,Ishikawa Toru,Shima Toshihide,Okanoue Takeshi

Publisher

Elsevier BV

Subject

Hepatology

Reference19 articles.

1. A sustained viral response is associated with reduced liver-related morbidity and mortality in patients with hepatitis C virus;Singal;Clin Gastroenterol Hepatol,2010

2. Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C;Iwasaki;Hepatology,2006

3. The effect of age on response to therapy with peginterferon alpha plus ribavirin in a cohort of patients with chronic HCV hepatitis including subjects older than 65 yr;Antonucci;Am J Gastroenterol,2007

4. Efficacy of peginterferon-α-2b plus ribavirin in patients aged 65 years and older with chronic hepatitis C;Honda;Liver Int,2010

5. Effect of aging on risk of hepatocellular carcinoma in chronic hepatitis C virus infection;Asahina;Hepatology,2010

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of hepatocellular carcinoma occurrence after antiviral therapy for patients with chronic hepatitis C Infection: a systematic review and meta-analysis;Hepatology International;2024-07-05

2. Comparison of six hepatocellular carcinoma prediction models in Japanese patients after sustained virologic response undergoing rigorous surveillance for hepatocellular carcinoma;Journal of Gastroenterology and Hepatology;2024-01-30

3. Misunderstanding of hepatitis C virus (HCV) infection status by non–specialized medical doctors in patients who achieved sustained virologic response to anti-HCV therapy;Journal of Infection and Chemotherapy;2022-09

4. Efficacy and safety of direct‐acting antiviral therapy for hepatitis C virus in elderly patients (≥65 years old): A systematic review and meta‐analysis;Journal of Viral Hepatitis;2022-04-06

5. Adherence to regular surveillance visits for hepatocellular carcinoma in patients with chronic hepatitis C virus infection who achieved sustained virologic response;European Journal of Gastroenterology & Hepatology;2022-02-14